or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 20.96 -2.65% -0.57
    DNLI closed down 2.65 percent on Thursday, September 28, 2023, on approximately normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -2.65%
    Doji - Bullish? Reversal -2.65%
    New 52 Week Low Weakness -2.65%
    Oversold Stochastic Weakness -2.65%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    60 Minute Opening Range Breakdown about 8 hours ago
    Lower Bollinger Band Support about 12 hours ago
    Down 3% about 13 hours ago
    Fell Below Lower Bollinger Band about 13 hours ago
    Outside Day about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 11 Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
    Sep 9 10 Biotech Stocks with Biggest Upside
    Sep 7 Why Is Denali Therapeutics Inc. (DNLI) Down 0.1% Since Last Earnings Report?
    Aug 30 Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023
    Aug 29 Invaio achieves first registration for citrus greening solution featuring Trecise™ technology
    Aug 11 20 Countries that Have the Most Billionaires Per Capita
    Aug 10 Denali (DNLI) Q2 Earnings Beat on Higher Collaboration Revenues
    Aug 10 Pinning Down Denali Therapeutics Inc.'s (NASDAQ:DNLI) P/S Is Difficult Right Now
    Aug 8 Denali Therapeutics Inc. (DNLI) Tops Q2 Earnings and Revenue Estimates
    Aug 8 Denali Therapeutics EPS of $1.30, revenue of $294.12M beats by $254.61M
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 34.78
    52 Week Low 20.82
    Average Volume 615,608
    200-Day Moving Average 27.13
    50-Day Moving Average 24.47
    20-Day Moving Average 22.99
    10-Day Moving Average 22.07
    Average True Range 0.87
    RSI (14) 29.08
    ADX 22.82
    +DI 15.84
    -DI 25.68
    Chandelier Exit (Long, 3 ATRs) 22.57
    Chandelier Exit (Short, 3 ATRs) 23.42
    Upper Bollinger Bands 25.16
    Lower Bollinger Band 20.83
    Percent B (%b) 0.03
    BandWidth 18.87
    MACD Line -0.85
    MACD Signal Line -0.72
    MACD Histogram -0.1217
    Fundamentals Value
    Market Cap 2.5 Billion
    Num Shares 119 Million
    EPS -0.58
    Price-to-Earnings (P/E) Ratio -35.95
    Price-to-Sales 265.35
    Price-to-Book 8.24
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.30
    Resistance 3 (R3) 22.40 22.05 22.07
    Resistance 2 (R2) 22.05 21.71 22.00 22.00
    Resistance 1 (R1) 21.51 21.50 21.34 21.41 21.93
    Pivot Point 21.16 21.16 21.08 21.11 21.16
    Support 1 (S1) 20.62 20.82 20.44 20.51 19.99
    Support 2 (S2) 20.27 20.61 20.22 19.92
    Support 3 (S3) 19.73 20.27 19.85
    Support 4 (S4) 19.62